Plasma and urinary C-peptide in the classification of adult diabetics

References

• Hoekstra J BL, van Rijn H JM, Erkelens D W, Thijssen J HH. C‐peptide. Diabetes Care 1982; 5: 438–46
   PubMed Web of Science ®Google Scholar
• Malmquist J, Lindgärde F, Aimër L ‐O, Johansson E. C‐peptiden från proinsulin‐teori åch praktik. Läkartidningen 1982; 79: 2716–9
   Google Scholar
• Kurtz A B, Nabarro J DN. Circulating insulin‐binding antibodies. Diabetologia 1980; 19: 329–34
   PubMed Web of Science ®Google Scholar
• Heding L G, Kasperska‐Czyzykowa T. C‐peptide and proinsulin after oral glucose. Acta Med Scand 1980; 639: 33–6, Suppl.
   Google Scholar
• Mirel R D, Ginsberg‐Fellner F, Horwitz D L, Rayfield E J. C‐peptide reserve in insulin‐dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide. Diabetologia 1980; 19: 183–8
   PubMed Web of Science ®Google Scholar
• Ludvigsson J. Methodological aspects on C‐peptide measurements. Acta Med Scand 1983; 671: 53–9, Suppl.
   Google Scholar
• Hendriksen C, Faber O K, Drejer J, Binder C. Prevalence of residual B‐cell function in insulin‐treated diabetics evaluated by the plasma C‐peptide response to intravenous glucagon. Diabetologia 1977; 13: 615–9
   PubMed Web of Science ®Google Scholar
• Zilker T. Bedeutung der C‐peptidbestimmung für therapie und prognose beim diabetes. Kombinationstherapie Insulin/Sulfonylharnstoff, W Bachmann, H Mehnert. S Karger AG, Basel 1983; 43–54
   Google Scholar
• Beischer W, Kerner W, Raptis S, Keller L, Beischer B, Pfeiffer E F. Insulin therapy in relation to circulating C‐peptide levels. Diabetes 1978; 27(Suppl. 1)235–40
   PubMed Web of Science ®Google Scholar
• Ahrén B, Lundquist I, Hedner P, Valdemarsson S, Scherstén B. Glucose tolerance and insulin and C‐peptide responses after various insulin secretory stimuli in hyper‐ and hypothyroid subjects before and after treatment. Diabetes Research 1985; 2: 95–103
   Google Scholar
• Rendell M. C‐peptide levels as a criterion in treatment of maturity‐onset diabetes. J Clin Endocrinol Metab 1983; 57: 1198–206
   PubMed Web of Science ®Google Scholar
• Turkington R W, Estkowski A, Link M. Secretion of insulin or connecting peptide. A predictor of insulin dependence of obese ‘diabetics’. Arch Intern Med 1982; 142: 1102–5
   PubMedGoogle Scholar
• Madsbad S, Krarup T, McNair P, et al. Practical clinical value of the C‐peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 1981; 210: 153–6
   PubMedGoogle Scholar
• Katzeff H L, Savage P J, Barclay‐White B, Nagulesparan M, Bennett P H. C‐peptide measurement in the differentiation of type 1 (insulin‐dependent) and type 2 (non‐insulin‐dependent) diabetes mellitus. Diabetologia 1985; 28: 264–8
   Google Scholar
• Koskinen P, Viikari J, Irjala K, Kaihola H ‐L, Seppälä P. C‐peptide determination in the choice of treatment in diabetes mellitus. Scand J Clin Lab Invest 1985; 45: 589–97
   PubMed Web of Science ®Google Scholar
• Kuzuya T, Matsuda A, Sakamoto Y, Tanabshi S, Kajinuma H. C‐peptide immunoreactivity (CPR) in urine. Diabetes 1978; 27(Suppl. 1)210–5
   Google Scholar
• Meistas M T, Zadik Z, Margolis S, Kowarski A. Correlation of urinary excretion of C‐peptide with the integrated concentration and secretion rate of insulin. Diabetes 1981; 30: 639–43
   PubMed Web of Science ®Google Scholar
• Aurbach‐Klipper J, Sharph‐Dor R, Heding L G, Karp M, Laron Z. Residual B‐cell function in diabetic children as determined by urinary C‐peptide. Diabetologia 1983; 24: 88–90
   Google Scholar
• Meistas M T, Rendell M, Margolis S, Kowarski A. Estimation of the secretion rate of insulin from the urinary secretion rate of C‐peptide. Study in obese and diabetic subjects. Diabetes 1982; 31: 449–53
   PubMed Web of Science ®Google Scholar
• Brodows R G. Use of urinary C‐peptide to estimate insulin secretion during starvation. J Clin Endocrinol Metab 1985; 61: 654–7
   Google Scholar
• Wood R J, Bengoa J M, Rosenberg I H. Urinary C‐peptide measurements in patients receiving continuous and cyclic total parenteral nutrition. J Lab Clin Med 1985; 105: 259–64
   Google Scholar
• Hoogwerf B J, Goetz F C. Urinary C‐peptide: a simple measure of integrated insulin production with emphasis on the effects of body size, diet and corticosteroids. J Clin Endocrinol Metab 1983; 56: 60–7
   Google Scholar
• Blix P M, Boddie‐Willis C, Landau R L, Rochman H, Rubenstein A H. Urinary C‐peptide: an indicator of β‐cell secretion under different metabolic conditions. J Clin Endocrinol Metab 1982; 54: 574–80
   PubMedGoogle Scholar
• Fernandez‐Castañer M, Rosel P, Ricart W, Soler J, Bonnin R, Navarro M A. Urinary C‐peptide in 2‐h urine collections after glucagon or breakfast: a valuable index of β‐cell secretion in diabetes. Diabetologia 1984; 27: 274A
   Google Scholar
• Rappaport E B, Ulstrom R A, Etzwiler D D, Fife D, Hedlund B E, Steffes M W. Urine C‐peptide, β‐cell function, and insulin requirement. Am J Dis Child 1980; 134: 1129–33
   Google Scholar
• Bantle J P, Laine D C, Hoogwerf B J, Goetz F C. The potential usefulness of postprandial urine C‐peptide measurement in classifying diabetic patients. Diabetes Care 1984; 7: 202–3
   Google Scholar
• Faber O K, Binder C. C‐peptide response to glucagon. A test for the residual β‐cell function in diabetes mellitus. Diabetes 1977; 26: 605–10
   PubMed Web of Science ®Google Scholar
• Scholer A, Pianezzi A. Mikromethode zur Bestimmung der Glukosekonzentration mit Glukose‐Dehydrogenase auf dem Auto‐Analyser. J Clin Chem Clin Biochem 1976; 14: 189–95
   PubMedGoogle Scholar
• Snedecor G W, Cochran W S. Statistical Methods6th edn. Ames, Iowa 1981; 78–81
   Google Scholar
• Groop L. Heterogeneity of type II diabetes. A study of clinical, genetic, immunological and metabolic aspects. Helsinki University, Dissertation Helsinki 1982; 124
   Google Scholar
• Garcia‐Webb P, Bonser A, Whiting D. Importance of fasting plasma glucose concentration and obesity in the interpretation of fasting serum C‐peptide values. Clin Chim Acta 1982; 118: 323–6
   PubMed Web of Science ®Google Scholar
• Garcia‐Webb P, Zimmet P, Bonser A, King H, Bottomley S. Factors affecting fasting serum C‐peptide levels in Micronesians: a comparison with a Caucasoid population. Diabetologia 1984; 27: 23–6
   PubMed Web of Science ®Google Scholar
• Birgerstam G, Malmquist J. Fasting plasma C‐peptide levels in health and impaired glucose tolerance: relations to blood glucose and relative body weight. Scand J Clin Lab Invest 1985; 45: 707–12
   PubMed Web of Science ®Google Scholar
• Groop L. Laboratoriediagnostik vid diabetes mellitus. Fin LØakaresØallsk Handl 1981; 125: 217–25
   Google Scholar
• Regeur L, Faber O K, Binder C. Plasma C‐peptide in uraemic patients. Scand J Clin Lab Invest 1978; 38: 771–5
   PubMed Web of Science ®Google Scholar